HCM: Prakiraan pendapatan perusahaan HUTCHMED (China) Limited

Logo grafis Hutchison MediPharma (HCM)

HUTCHMED (HCM) relies on drug distribution in the PRC, which mitigates development risks. By comparing the company's future sales revenues on GURU.Markets, we see that the indicator has reached the level of 2.60. This is based on heavy R&D investments in precision therapy, although global distrust of Chinese biotech and pressure from Western behemoths create serious barriers to expansion.

HCM - Prakiraan dodolan perusahaan hutch-med.com ing rentang 04.07.2022 - 17.11.2026

Rincian metrik keuangan lan pasar HUTCHMED (China) Limited (HCM)

- nilai saham lan prakiraan konsensus rega:
Ringkesan analisis perusahaan:HUTCHMED
Sampel barang HUTCHMED Corp

For an investor in HUTCHMED (China) Limited, this indicator serves as a tool to verify the commercial potential of innovative oncology drugs amidst global expansion. The mathematical model generating the revenue forecast excludes management manipulations by assessing the issuer's net market value through daily equilibrium analysis, which confirms the business's fundamental stability and the absence of anomalies in its growth trajectory.

Pesaing langsung

Prakiraan pendapatan perusahaan Incyte Pharma (INCY)|NUVB - Volume dodolan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan Day One Bio DAWN|Monopar Corp - Prakiraan pendapatan perusahaan|INBX - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan i-mabbiopharma.com|FENC: Prakiraan volume dodolan|Prakiraan dodolan perusahaan Heron Therapeutics HRTX|Volume dodolan mangsa ngarep perusahaan NVCT|Volume dodolan sing dikarepake perusahaan Coherus Biosciences CHRS|Volume dodolan mangsa ngarep perusahaan CRBP (Corbus Pharmaceuticals)|CRDF (Cardiff Oncology Corp) - Pendapatan mangsa ngarep perusahaan|BeyondSpring Inc. - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume pendapatan perusahaan BCAB (BioAtla Corp)|Lixte Biotechnology Holdings - Prakiraan volume dodolan|Pendapatan mangsa ngarep perusahaan CTXR (citiuspharma.com)|CLRB: Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan biolinerx.com (BLRX)|Prakiraan pendapatan perusahaan Can-Fite BioPharma Ltd.|APRE: Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan KZIA|Prakiraan volume dodolan Silexion Therapeutics Corp. (SLXN)|Prakiraan pendapatan perusahaan NuCana PLC NCNA|CMRX (Chimerix) - Pendapatan sing dikarepake perusahaan|CYCC: Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan g1therapeutics.com|Kronos Bio Inc (KRON) - Prakiraan pendapatan perusahaan|Kintara (KTRA) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan Oncternal Therapeutics, Inc.|Volume dodolan sing dikarepake perusahaan portagebiotech.com PRTG